Skip to content

Clinical trials

Phase 2 Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 2 Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20042
20052
20061
20074
20083
20092
20102
20123
20132
20141
20151
20162
20173
20183
20201
20215
20222
20232
20242
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting10
Terminated7
Active, not recruiting5
Unknown status4
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center7
Fondazione IRCCS Policlinico San Matteo di Pavia4
Mayo Clinic4
Memorial Sloan Kettering Cancer Center4
Barbara Ann Karmanos Cancer Institute3
Peking Union Medical College Hospital3
Prothena Biosciences Ltd.3
SWOG Cancer Research Network3
Case Comprehensive Cancer Center2
Herbert Irving Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis69
Multiple Myeloma29
Neoplasms, Plasma Cell17
Amyloidosis10
Leukemia, Lymphocytic, Chronic, B-Cell9
Burkitt Lymphoma8
Lymphoma, B-Cell, Marginal Zone8
Lymphoma, Follicular8
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Large-Cell, Immunoblastic8

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.